Erudio Healtherudio.com
Clinical trial · no report yet · Phase 2
NIVINIHO
Study Of Nivolumab Alone, Or In Combination With Vinblastin In Patients With Classical Hodgkin Lymphoma
- NCT03580408 ↗
- Completed
- The Lymphoma Academic Research Organisation
- Focused
We haven't built an HCP commentary report on NIVINIHO (nivolumab plus vinblastine; nivolumab in elderly Hodgkin lymphoma with coexisting medical conditions) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on NIVINIHO so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 3 |
The trial
ClinicalTrials.gov- Official title
- A Prospective Phase II Study Of Nivolumab Alone, Or In Combination With Vinblastin In Patients Aged 61 Years And Older, With Classical Hodgkin Lymphoma And Coexisting Medical Conditions.
- Phase
- Phase 2
- Status
- Completed
- Conditions
- Hodgkin Lymphoma; Coexisting Medical Conditions
- Interventions
- Nivolumab; Vinblastin
- Arms
- Experimental · Experimental
- Enrollment
- 64
- Primary outcomes
- Complete Metabolic Response (CMR) rate (Deauville scale 1-3) at the end of treatment
- Sponsor
- The Lymphoma Academic Research Organisation
- Start
- Aug 31, 2018
- Primary completion
- Feb 19, 2021
- Results posted
- No
- Registry record
- NCT03580408 · updated Aug 19, 2022
Publications
linked from the registry- Lazarovici J, Amorim S, Bouabdallah K, Fournier M, Guidez S, Molina L, Morschhauser F, Delapierre B, Gastinne T, Laribi K, Launay V, Slama B, Belmecheri N, Casasnovas RO, Corby A, Durot E, Feugier P, Nicolas-Virelizie E, Sibon D, Berriolo-Riedinger A, Edeline V, Borght TV, Damotte D, Traverse-Glehen A, Ribrag V, Andre M. Nivolumab with or without vinblastine for first-line treatment of elderly patients with Hodgkin lymphoma and coexisting medical conditions: the Niviniho phase II Lysa study. Haematologica. 2026 May 28. doi: 10.3324/haematol.2025.300166. Online ahead of print. PubMed 42206423